Tumor of germinal ovari cells: clinical characteristics and results from the treatment

Armando Quero-Hernández; Reyna Estrada-Correa; Héctor Tenorio-Rodríguez; Rubén M Álvarez-Solís

2007, Number 2

<< Back Next >>

Cir Cir 2007; 75 (2)

Tumor of germinal ovari cells: clinical characteristics and results from the treatment

Quero-Hernández A, Estrada-Correa R, Tenorio-Rodríguez H, Álvarez-Solís RM

Full text

How to cite this article

Language: Spanish
References: 21
Page: 81-85
PDF size: 51.63 Kb.

ABSTRACT

Background: Ovarian malignant neoplasms in young girls and teenagers are unusual. The most frequent histological subtypes found are those derived from germ cells. The biological course of this heterogeneous group of neoplasm is unpredictable. The main clinical symptom is chronic abdominal pain and palpable abdominal tumor. Treatment has been improved with combined modality therapy. We present treatment results of the germ cell subtype of malignant ovarian tumors.
Methods: A retrospective review was performed from the medical records of 16 ovarian germ cell patients in order to analyze clinical characteristics, type of surgery performed and chemotherapy, as well as final treatment results.
Results: Mean age was 13.8 years, and the left ovary was affected in 75% of cases. The most frequent histological subtype was dysgerminoma (56%). Stage distribution was as follows: stage I, one patient diagnosed with choriocarcinoma; stage II, three cases (19%); stage III, 10 cases; and 2 cases in stage IV. Biopsy was performed in 70% of cases. Mean number of chemotherapy cycles (cisplatin, etoposide and bleomycin) was 4, and 85% of patients survived ›2 years.
Conclusions: Surgical procedure was conservative and a favorable outcome was observed for the chemotherapy cycles.

REFERENCES

Gobel U, Schneider DT, Calaminas G, Haas RJ, Schmidt P, Harmas D. Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO Study Groups. Ann Oncol 2000;11:263-271.
2. Quero-Hernández A, Hernández-Arriola J, Socorro-López Z, Pérez-Bautista A. Tumores de ovario en niñas y adolescentes. Rev Mex Pediatr 2005;72:174-178.
3. Castleberry R, Cushing B, Hawkins E. Germ cell tumors. In: Pizzo P, Poplack D, eds. Principles of Pediatric Oncology. 3rd ed. Philadelphia: Lippincott-Raven;1997. pp. 921- 945.
4. Moller H, Evans H. Epidemiology of gonadal germ cell cancer in males and females. APMIS 2003;111:43-46.
5. Fajardo G, Mendoza H, Valdéz E, et al. Frecuencia de neoplasias malignas en niños atendidos en hospitales del Distrito Federal. Estudio multicéntrico. Bol Med Hosp Infant Mex 1996;53:57-66.
6. Rescorla FJ. Pediatric germ cell tumors. Semin Surg Oncol 1999;16:144-158.
7. Low JJ, Perrin LC, Crandon AJ, Hacker NF. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer 2000;89:391-398.
8. Gonzalo-Alonso E, Merino-Marcos I, Fernández-Teijeiro Álvarez A, Astigarraga-Aguirre I, Navajas-Gutiérrez A. Ovarian tumors in childhood: apropos of a review of cases. An Esp Pediatr 1998;45:491-495.
9. Skinner MA, Schlatter MG, Heifetz SA, Grosfeld JL. Ovarian neoplasms in children. Arch Surg 1993;128:849-853.
10. Billmire D, Vinocur C, Rescorla F, Cushing B, London W, Schlatter M. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg 2004;39:424-429.
11. Suita S, Shono K, Tajiri T, Takamatsu T, Mizote H, Nagasaki A, et al. Malignant germ cell tumors: clinical characteristics, treatment, and outcome. A report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan. J Pediatr Surg 2002;37:1703-1706.
12. Piippo S, Mustaniemi L, Lenko H, Aine R, Maenpaa J. Surgery for ovarian masses during childhood and adolescence: a report of 79 cases. J Pediatr Adolesc Gynecol 1999;12:223-227.
13. Cass DL, Hawkins E, Brandt ML, Chintagumpala M, Bloss RS, Milewicz AL, et al. Surgery for ovarian masses in infants, children, and adolescents: 102 consecutive patients treated in a 15-year period. J Pediatr Surg 2001;36:693-699.
14. Stern JW, Bunin N. Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors. Med Pediatr Oncol 2002;39:163-167.
15. Teinturier C, Gelez J, Flamant F, Habrand JL, Lemerle J. Pure dysgerminoma of the ovary in childhood: treatment results and sequelae. Med Pediatr Oncol 1994;23:1-7.
16. Gershenson DM, Morris M, Cangir A, Kavanagh JJ, Stringer CA, Edwards CL, et al. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 1990;8:715-720.
17. Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: A Pediatric Intergroup Study-Pediatric Oncology Group 9094 and Childrens Cancer Group 8882. J Clin Oncol 2004;22:2691-2700.
18. Knopf K, Kohn E. Ovarian cancer. In: Abraham J, Allegra CJ, eds. Handbook of Clinical Oncology. Philadelphia: Lippincott Williams and Wilkins;2001. pp. 191-202.
19. Akyuz C, Varan A, Buyukpamukcu N, Kutluk T, Buyukpamukcu M. Malignant ovarian tumors in children: 22 years of experience at a single institution. J Pediatr Hematol Oncol 2000;22:422-427.
20. Kanazawa K, Susuki T, Sakumoto K. Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission. Am J Clin Oncol 2000;23:244-248.
21. Terenziani M, Massimino M, Casanova M, Cefalo G, Ferrari A, Luksch R, et al. Childhood malignant ovarian germ cell tumors: a monoinstitutional experience. Gynecol Oncol 2001;81:436-440.